Section of Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
Department of Cardiovascular Disease Research, Novo Nordisk, Måløv, Denmark.
J Endocrinol. 2021 Mar;248(3):289-301. doi: 10.1530/JOE-20-0608.
The glucagon-like peptide-1 receptor (GLP1R) is expressed in the renal vasculature and known to be downregulated under hypertensive conditions in rats and humans. However, little is known about the regulation in other types of renal pathology involving vascular changes. This study investigates the expression of the GLP1R in renal vasculature after glomerular injury in the nephrotoxic nephritis mouse model, high cholesterol, and atherosclerosis in the Ldlr-/- mouse on Western diet, and ex vivo injury in an organ culture model. The immunohistochemical signal of the GLP1R was significantly decreased in arteries from mice with nephrotoxic nephritis after 42 days compared to 7 days and saline control (P < 0.05). Histological evaluation of kidneys from Ldlr-/- mice on Western diet showed a decreased GLP1R specific immunohistochemical signal (P < 0.05). The dilatory response to liraglutide was decreased in Western diet fed Ldlr-/- mice compared to C57Bl/6J controls (P < 0.05). Organ culture significantly decreased the immunohistochemical signal of the GLP1R (P <0.05) and the expression of Glp1r mRNA (P < 0.005) compared to fresh. Organ cultured vessels showed vascular smooth muscle cell remodelling as Acta2 expression was decreased (P < 0.005) and Ednrb was increased (P < 0.05). In conclusion, nephrotoxic nephritis and hypercholesterolaemia led to decreased GLP1R specific immunohistochemical signal. Ex vivo vascular injury in the organ culture model leads to a decrease in expression of GLP1R expressionand contractile VSMC specific markers and increase in expression of dedifferentiation markers suggestive of an inverse relationship between phenotypic switch of the VSMC and the expression of the GLP1R; however, the causal relationship remains elusive.
胰高血糖素样肽-1 受体 (GLP1R) 在肾脏血管中表达,已知在大鼠和人类的高血压情况下会下调。然而,对于涉及血管变化的其他类型的肾脏病理学中调节知之甚少。本研究调查了在肾毒性肾炎小鼠模型、高胆固醇和动脉粥样硬化的 LDLR-/-小鼠的 Western 饮食以及器官培养模型中的体外损伤后,肾小球损伤后肾脏血管中 GLP1R 的表达。与 7 天和生理盐水对照组相比,在 42 天时,肾毒性肾炎小鼠的动脉中 GLP1R 的免疫组织化学信号显著降低(P < 0.05)。Western 饮食喂养的 LDLR-/-小鼠肾脏的组织学评估显示 GLP1R 特异性免疫组织化学信号降低(P < 0.05)。与 C57Bl/6J 对照组相比,Western 饮食喂养的 LDLR-/-小鼠对利拉鲁肽的扩张反应降低(P < 0.05)。与新鲜标本相比,器官培养显著降低了 GLP1R 的免疫组织化学信号(P <0.05)和 Glp1r mRNA 的表达(P < 0.005)。与新鲜标本相比,器官培养的血管显示出血管平滑肌细胞重塑,因为 Acta2 表达降低(P < 0.005),Ednrb 表达增加(P < 0.05)。总之,肾毒性肾炎和高胆固醇血症导致 GLP1R 特异性免疫组织化学信号降低。在器官培养模型中体外血管损伤导致 GLP1R 表达和收缩性 VSMC 特异性标志物的表达降低,而分化标志物的表达增加,提示 VSMC 的表型转换与 GLP1R 的表达之间存在逆相关;然而,因果关系仍不清楚。